Beta-glucan cream added to standard skin care for IAD in hospitalized adults
Official title: Improving the Care of Incontinence-Associated Dermatitis (IAD) Using a Beta-Glucan Cream as a Hydrating and Soothing Agent
Run by University of Alberta · NCT07524439 · Data updated 2026-11-12
This study tests whether adding a 0.5% beta-glucan moisturizing cream to usual skin care helps adults with incontinence-associated dermatitis heal faster and feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Alberta Academic / other |
| Locations | 1 site (Edmonton, Alberta) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | May 1, 2027 |
| Study ends | November 30, 2028 |
| Registry record updated | June 26, 2026 |
| Trial ID | NCT07524439 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with IAD due to urinary and/or fecal incontinence and a hospital stay of at least 7 days.
✕Probably not a fit
Patients without IAD, with incontinence but no dermatitis, or with known hypersensitivity to cream components may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this interventional study, hospitalized adults with IAD will receive standard skin care with or without a 0.5% beta-glucan cream (Soothing Beta Cream) to see if the cream improves visible skin severity, accelerates healing, and reduces discomfort. The trial will compare outcomes using the Ghent Global IAD Monitoring Tool (GLOBIAD-M) and patient-reported symptoms. Safety and tolerability of the cream will also be monitored. Participants will be followed during their hospital stay, with assessments of skin condition and comfort.
Why it matters
Potential benefit: If successful, patients may experience faster healing, less redness and irritation, and improved comfort during care.
How similar studies have gone: Prior research in IAD management supports the potential benefit of moisturizers, though this specific beta-glucan formulation in hospitalized adults is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Eligible participants are adults (≥18 years) with IAD secondary to urinary and/or fecal incontinence and an expected hospital stay of ≥7 days. Written informed consent will be obtained directly or via substitute decision-maker. Exclusion criteria include absence of IAD or incontinence, pediatric patients, and participants with known hypersensitivities to components of cream (e.g. beta-glucan).
Where it's running
-
University of Alberta Hospital
Edmonton, Alberta, Canada Recruiting
Study contacts
- Principal investigator: Marlene Dytoc, MD/PhD — University of Alberta
- Study coordinator: Eileen Tang, BSc
- Email: eatang@ualberta.ca
- Phone: 7802636245
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating a new device for treating overactive bladder and bowel dysfunction
This study is testing a new device that uses electrical stimulation to see if it can help people with overactive bladder and bowel issues feel better.
-
Treatment of Overactive Bladder and Bowel Dysfunction with UCon Bar Electrode
This study is testing a new device to see if it can help women with overactive bladder and bowel issues feel better by using electrical stimulation.
-
Home biofeedback therapy for managing bowel and urinary issues
This study is testing a new home therapy using a wireless device and a phone app to help people with bowel and urinary issues feel better and see if it's easier and cheaper than going to the doctor.
-
Urinary incontinence in older adults: how leakage and bladder residuals relate to frailty
This study tests whether the severity of urinary leakage and leftover urine after voiding are linked to frailty and other geriatric outcomes in older adults visiting a urology clinic.
-
Compare two pelvic floor stimulation devices to see which helps with urinary incontinence in women
We’re testing if electromagnetic chair therapy can help women with mixed urinary incontinence as well as standard electrostimulation with biofeedback.
-
Educational video before urodynamic testing to see if it lowers anxiety
This study tests whether watching a short educational video before urodynamics helps reduce anxiety for women undergoing the test.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.